Earnings Previews: UiPath, Walgreens
Here are previews of two interesting companies set to report quarterly results after the markets close on Wednesday and before they open on Thursday.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The S&P 500 has hit its highest level since January (before the Russia-Ukraine conflict), and markets in general seem to be on the rebound, as peace talks between Russia and Ukraine are ongoing. With the prospect of a resolution to the conflict up in the air, global markets seem to be settling down.
With markets reenergized, analysts have been even more optimistic on where things could go from here. In fact, targets for the broad markets and earnings have been increasing of late, and analysts are calling for upside.
A couple of notable companies are expected to release quarterly results after markets close on Wednesday and before they open on Thursday. Here, 24/7 Wall St. has a close look at what to expect from these reports.
[nativounit]
UiPath
UiPath Inc. (NYSE: PATH | PATH Price Prediction) is a staple holding of Cathie Wood and her ARK Invest funds, as it is on the cutting edge of robotic process automation software. This company only came public in April 2021, and with less than one year in the books, analysts are calling for positive earnings, despite shares more-than halving since the initial public offering.
The firm is set to report its most recent results after the closing bell on Wednesday. Analysts are calling for earnings per share (EPS) of $0.03 and revenues of $283.57 million. While UiPath has been a story of investor pain over the past year, positive earnings could be the turning point.
[recirclink id=1077917]
UiPath stock posted a small loss in Wednesday’s premarket trading, with shares trading near $31. The stock has a 52-week trading range of $23.93 to $90.00 and a consensus price target of $57.68. The market cap is $16.5 billion.
Walgreens
Walgreens Boots Alliance Inc. (NASDAQ: WBA) is one of the biggest nationwide drug-store retail chains that offers prescription-based services and beauty, personal care and other products. The company operates nearly nine thousand locations under the Walgreens and Duane Reade brands in the United States. The International segment also operates over four thousand locations under similar banners. With such a huge global footprint, Walgreens can expect some big earnings going forward.
Look for Walgreens to report its quarterly results first thing on Thursday. Analysts are calling for $1.39 in EPS on $33.38 billion in revenues. The same period from last year had $1.26 in EPS and $32.78 billion in revenue.
[wallst_email_signup]
Walgreens stock trended slightly lower on Wednesday morning, just below $48 a share, and it has a consensus price target of $53.43. The market cap is $41 billion, and the 52-week trading range is $43.62 to $57.05.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
